Chemoinformaics analysis of 1-(2-Hydroxy-4,6-dimethoxyphenyl)-3-phenylpropan-1-one
Molecular Weight | 286.327 | nRot | 6 |
Heavy Atom Molecular Weight | 268.183 | nRig | 13 |
Exact Molecular Weight | 286.121 | nRing | 2 |
Solubility: LogS | -4.583 | nHRing | 0 |
Solubility: LogP | 3.533 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
nHA | 4 | APOL | 43.6003 |
nHD | 1 | BPOL | 22.3977 |
QED | 0.828 |
Synth | 1.89 |
Natural Product Likeliness | 0.612 |
NR-PPAR-gamma | 0.604 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.314 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.797 |
MDCK | 0.0000193 |
BBB | 0.578 |
PPB | 0.95812 |
VDSS | 0.513 |
FU | 0.0184833 |
CYP1A2-inh | 0.982 |
CYP1A2-sub | 0.944 |
CYP2c19-inh | 0.964 |
CYP2c19-sub | 0.476 |
CYP2c9-inh | 0.87 |
CYP2c9-sub | 0.938 |
CYP2d6-inh | 0.921 |
CYP2d6-sub | 0.897 |
CYP3a4-inh | 0.835 |
CYP3a4-sub | 0.373 |
CL | 10.444 |
T12 | 0.493 |
hERG | 0.103 |
Ames | 0.223 |
ROA | 0.109 |
SkinSen | 0.699 |
Carcinogencity | 0.194 |
EI | 0.919 |
Respiratory | 0.625 |
NR-Aromatase | 0.063 |
Antiviral | Yes |
Prediction | 0.608565 |